Jacobsen Capital Management
Source: SEC Form 13F · as of Mar 2026Jacobsen Capital Management holds 11 biotech & pharma companies tracked by BioSniper, totaling $6.2M in value as of Mar 2026 (SEC Form 13F).
Companies held
11
Total value held
$6.2M
| Company | Shares | Value |
|---|---|---|
| LLYELI LILLY & Co | 1,538 | $1.4M |
| JNJJOHNSON & JOHNSON | 4,707 | $1.2M |
| ABBVAbbVie Inc. | 3,633 | $790K |
| MRKMerck & Co., Inc. | 4,758 | $572K |
| PMPhilip Morris International Inc | 2,582 | $427K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 1,341 | $363K |
| AMGNAMGEN INC | 999 | $351K |
| ABTABBOTT LABORATORIES | 3,183 | $327K |
| PFEPFIZER INC | 10,980 | $308K |
| GILDGILEAD SCIENCES, INC. | 1,994 | $278K |
| MCKMcKesson Corporation | 255 | $221K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.